Shares of CSL Limited (OTCMKTS:CSLLY - Get Free Report) hit a new 52-week low during trading on Tuesday . The stock traded as low as $80.22 and last traded at $80.96, with a volume of 68426 shares. The stock had previously closed at $84.59.
Analyst Ratings Changes
Separately, The Goldman Sachs Group raised shares of CSL to a "strong-buy" rating in a research note on Thursday, January 16th.
Get Our Latest Research Report on CSL
CSL Trading Up 0.1 %
The company has a debt-to-equity ratio of 0.58, a current ratio of 2.18 and a quick ratio of 0.97. The stock has a 50-day simple moving average of $86.60 and a 200-day simple moving average of $93.99.
CSL Company Profile
(
Get Free Report)
CSL Limited researches, develops, manufactures, markets, and distributes biopharmaceutical and vaccines in Australia, the United States, Germany, the United Kingdom, Switzerland, China, Hong Kong, and internationally. The company operates through CSL Behring, CSL Seqirus, and CSL Vifor segments. The CSL Behring segment offers plasma products, gene therapies, and recombinants.
Featured Articles
Before you consider CSL, you'll want to hear this.
MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and CSL wasn't on the list.
While CSL currently has a Strong Buy rating among analysts, top-rated analysts believe these five stocks are better buys.
View The Five Stocks Here
Unlock the timeless value of gold with our exclusive 2025 Gold Forecasting Report. Explore why gold remains the ultimate investment for safeguarding wealth against inflation, economic shifts, and global uncertainties. Whether you're planning for future generations or seeking a reliable asset in turbulent times, this report is your essential guide to making informed decisions.
Get This Free Report
Like this article? Share it with a colleague.
Link copied to clipboard.
